← Comparing 1 hypotheses side-by-side
Add hypothesis:
— Select a hypothesis to add —
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neuroinfla (TREM2) — 0.00 Kinetic Threshold Model Predicts CHIP-Mediated Clearance Req (STUB1) — 0.00 NAD+-Dependent Upregulation of MCT1 Expression to Restore Ne (SLC16A1 (MCT1)) — 0.00 LXRα-Selective Agonism to Enhance Hepatic APOE Secretion and (LXRα (NR1H3)) — 0.00 Enhancement of Astrocytic Ketone Body Production via HMGCS2 (HMGCS2) — 0.00 CD38 Inhibition to Preserve NAD+ Pools and Prevent PARP1-Med (CD38, PARP1, SIRT1/3) — 0.00 FUS-Enhanced AAV-PHP.eB Delivery for Microglial IGFBPL1 Expr (IGFBPL1) — 0.00 CRP-Mediated CCR2+ Monocyte Recruitment Drives Microglial IL (CCR2, TLR4, IL1B) — 0.00 LXRβ-Selective Agonism Enhances CYP2J2-Mediated DHA Epoxide (NR1H2 (LXRβ)) — 0.00 Rare TREM2-TYROBP pathway variants complement standard PRS b (PLCG2) — 0.00 Closed-loop transcranial focused ultrasound with adaptive AP (PVALB) — 0.00 Circulating hs-CRP as Disease-Modifying Target via Astrocyti (CRP → NLRP3 → IL-1β/IL-18) — 0.00 CCL2 Gradient Disruption via Astrocytic CXCL12 Upregulation (CXCL12) — 0.00 TBK1 Loss Drives Motor Neuron Death Through Impaired Mitopha (TBK1 → OPTN / p62 / FIP200 / mitophagy machinery) — 0.00 Dynamic Blood-Based Exosome Panel for Real-Time Neuroinflamm (CHI3L1/TREM2/NRGN) — 0.00 AD Polygenic Risk Score predicts transcriptomic aging accele (%s) — 0.00 Lentiviral-Mediated Astrocytic IGFBPL1 Expression via GFAP P (IGFBPL1) — 0.00 CSF TREM2 Fragment Ratio Integrated with Neuroinflammatory C (TREM2) — 0.00 Plasma TREM2 Ectodomain Glycosylation Patterns as Microglial (TREM2/ST6GAL1/MGAT5) — 0.00 SASP-Secreted MMP-9 from Senescent Microglia Disrupts TDP-43 (MMP9 → nuclear import machinery (KPNA1, NUP proteins, LMNA) → TARDBP cytoplasmic mislocalization) — 0.00 Astrocytic TREM2-Like Receptor Modulation of Synaptic Streng (TREML2) — 0.00 Mitochondrial Dysfunction-Mediated Neurodegeneration in Alzh (TFAM) — 0.00 TREM2-Mediated Microglial Regulation of Oligodendrocyte Prec (TREM2) — 0.00 Microglia-Mediated Synaptic Pruning Modulation to Optimize F (CX3CR1) — 0.00 TBK1 Loss Drives Microglial Senescence-SASP to Generate MMP- (TBK1) — 0.00 Ultrasound-Responsive Liposomal Nanocarriers with Thermosens (IGFBPL1) — 0.00 Optogenetic restoration of SST interneuron-mediated dendriti (SST) — 0.00 CCR2-Mediated Microglial Replacement Drives mTOR-HIF1α Metab (CCR2) — 0.00 CCR2-Mediated Microglial Replacement Drives mTOR-HIF1α Metab (CCR2) — 0.00 TREM2-Mediated Senescent Microglial Reprogramming of Astrocy (TREM2) — 0.00
Add
|
× [Archived Hypothesis]
- · - · mechanistic
Composite 0.300
Price $0.30
Evidence For 0
Evidence Against 0
Radar Chart — 10 Dimensions
Score Breakdown
Dimension [Archived Hypothesis] Mechanistic 0.000 Evidence 0.300 Novelty 0.000 Feasibility 0.000 Impact 0.000 Druggability 0.000 Safety 0.000 Competition 0.000 Data 0.000 Reproducible 0.000 KG Connect 0.500
Evidence [Archived Hypothesis] No evidence citations yet
Debate Excerpts [Archived Hypothesis] 4 rounds · quality: 0.81
Theorist # Legacy Pre-Pipeline Hypotheses: Neurodegeneration
---
## Hypothesis 1: Exosomal α-Synuclein as an Interneuronal Propagation Vector in Parkinson's Disease
**Mechanism:** Misfolded α-synuclein (aSy...
Skeptic # Critical Evaluation of Legacy Pre-Pipeline Hypotheses
## General Methodological Concerns (Cross-Cutting Issues)
Before evaluating individual hypotheses, several systemic weaknesses affect the enti...
Domain Expert # Comprehensive Feasibility Assessment: Legacy Neurodegeneration Hypotheses
## Preamble
This assessment evaluates each hypothesis across five critical domains using a standardized framework. Evidenc...
Synthesizer ```json
{
"ranked_hypotheses": [
{
"title": "TREM2-Deficient Microglia as Drivers of Amyloid Plaque Toxicity in Alzheimer's Disease",
"description": "TREM2 loss-of-function variants ...
Price History Overlay